Skip to search formSkip to main contentSkip to account menu

erythromycin oxime

Known as: Erythromycin, 9-oxime, Erythromycin-9-oxime, Erythromycin A Oxime 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Erythromycin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The Oxime Portmanteau Motif: Released Heteroradicals Undergo Incisive EPR Interrogation and Deliver Diverse Heterocycles
Conspectus Selective syntheses are now available for compounds of many classes, based on C-centered radicals, exploiting a… 
Highly Cited
2012
Highly Cited
2012
Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
A new class of amidine-oxime reactivators of organophosphate (OP)-inhibited cholinesterases (ChE) was synthesized and tested in… 
Highly Cited
2009
Highly Cited
2009
Cutting Edge: Necrosis Activates the NLRP3 Inflammasome1
Cells undergoing necrosis release endogenous danger signals that possess proinflammatory potential. In this study we show that… 
Highly Cited
2006
Highly Cited
2006
The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.
Review
2003
Review
2003
Development of radicicol analogues.
Radicicol, a macrocyclic antibiotic produced by fungi, was originally isolated many years ago, and was described as tyrosine… 
Highly Cited
2003
Highly Cited
2003
A Comparison of the Ability of a New Bispyridinium Oxime—1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane Dibromide and Currently used Oximes to Reactivate Nerve Agent-inhibited Rat…
The efficacy of a new bispyridinium oxime 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide, called… 
Review
2002
Review
2002
Review of Oximes in the Antidotal Treatment of Poisoning by Organophosphorus Nerve Agents
The cholinesterase-inhibiting organophosphorus compounds referred to as nerve agents (soman, sarin, tabun, GF agent, and VX) are… 
Highly Cited
2001
Highly Cited
2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
We describe here the identification and properties of SCH-C (SCH 351125), a small molecule inhibitor of HIV-1 entry via the CCR5… 
Highly Cited
1993
Highly Cited
1993
Pharmacological modulation of soman-induced seizures
Highly Cited
1974
Highly Cited
1974
The reactivatibility of cholinesterase inhibited by VX and sarin in man.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)